BMY vs REGN — Performance Comparison
Side-by-side percent change for Bristol-Myers Squibb Company (BMY), Regeneron Pharmaceuticals, Inc. (REGN) across every preset interval.
Over the past year, BMY is up 23.27% versus REGN up 19.17% — BMY ahead by 4.10%. Over the past 30 days, BMY is down 2.45% and REGN is down 7.53%. BMY trades at $56.47; REGN at $697.15.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $56.47 | -0.53% ★ | +0.04% ★ | +0.55% ★ | -2.45% ★ | -7.03% ★ | +4.69% ★ | +21.05% ★ | +23.27% ★ | -15.74% | -13.73% |
| REGN Regeneron Pharmaceuticals, Inc. | $697.15 | -2.21% | -3.63% | -2.48% | -7.53% | -13.20% | -9.68% | +0.53% | +19.17% | -6.08% ★ | +33.11% ★ |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
BMYBristol-Myers Squibb Company
$56.47-0.53% today
REGNRegeneron Pharmaceuticals, Inc.
$697.15-2.21% today